- The Magazine
Merck said results of a study into islatravir suggested it could be used to prevent and treat HIV
ViiV Healthcare's monthly injections are just as effective every two months, company announces
Just in time for International Condom Day, an unscientific poll of Metro Weekly readers finds almost 4 in 10 say they never use condoms during sex, with...
Viiv Healthcare's Cabenuva replaces a traditional daily pill regimen with two injections every month
Controversial rapper targets gay community for mockery after people criticized her religious beliefs
Bimonthly injections were previously found to be more effective than daily pills at preventing HIV transmission
Public Health England attributed the record low to increased testing, condom usage, and the availability of PrEP
LGBTQ lawmakers had to revive bill banning gay or trans panic defense after Senate leaders killed it for expediency
Supervisor Rafael Mandelman says outdated regulations haven't kept pace with changes in HIV testing and treatment
The man is in long-term HIV remission after a new drug combination, but scientists urge caution over results
GlaxoSmithKline stopped clinical trials of the PrEP drug early due to its efficacy at preventing new HIV transmissions
Three ongoing HIV vaccine trials offer reason to be hopeful, researchers say
NMAC's Paul Kawata on 30 years of fighting HIV, and the current state of the epidemic
But they note that there's no "cause for concern"
Five LGBTQ stories you need to know